Equities Research Analysts’ Downgrades for August, 15th (AER, ARII, ARW, BKCC, CYOU, GOL, JD, MEET, MRAM, NBRV)

Equities Research Analysts’ downgrades for Tuesday, August 15th:

Aercap Holdings N.V. (NYSE:AER) was downgraded by analysts at BidaskClub from a strong-buy rating to a buy rating.

American Railcar Industries (NASDAQ:ARII) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

Arrow Electronics (NYSE:ARW) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

BlackRock Capital Investment Corporation (NASDAQ:BKCC) was downgraded by analysts at BidaskClub from a sell rating to a strong sell rating.

Changyou.com Limited (NASDAQ:CYOU) was downgraded by analysts at BidaskClub from a strong-buy rating to a buy rating.

Gol Linhas Aereas Inteligentes SA (NYSE:GOL) was downgraded by analysts at BidaskClub from a buy rating to a hold rating.

JD.com (NASDAQ:JD) was downgraded by analysts at BidaskClub from a strong-buy rating to a buy rating.

MeetMe (NASDAQ:MEET) was downgraded by analysts at BidaskClub from a sell rating to a strong sell rating.

Everspin Tech (NASDAQ:MRAM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Everspin Technologies, Inc. is involved in designing, manufacturing and commercially shipping discrete and embedded Magnetoresistive RAM and Spin-Torque MRAM. It serves data center, cloud storage, energy, industrial, automotive and transportation markets. Everspin Technologies, Inc. is headquartered in Chandler, Arizona. “

Nabriva Therapeutics AG (NASDAQ:NBRV) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Nabriva Therapeutics AG is a biopharmaceutical company. The Company is involved in the research and development of novel anti-infective agents to treat serious infections, which focus on the pleuromutilin class of antibiotics. Its product candidate consists of BC-3781, developed for the treatment of serious skin infections and bacterial pneumonia caused by MRSA and other drug resistant bacteria; BC-7013, a topical pleuromutilin antibiotic which are in different clinical trial. Nabriva Therapeutics AG is based in Vienna, Austria. “

NCI (NASDAQ:NCIT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “NCI, Inc. is a leading provider of information technology services and solutions to U.S. federal government agencies. NCI’s award-winning expertise encompasses areas critical to its customers’ mission objectives including enterprise systems management, information assurance, network engineering, and systems development and integration. “

NMI Holdings (NASDAQ:NMIH) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

Nomad Foods Limited (NYSE:NOMD) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Nomad Foods Ltd. manufactures and distributes frozen foods primarily in the United Kingdom, Italy, Germany, Sweden, France and Norway. The Company’s portfolio of frozen food brands includes Birds Eye, Iglo and Findus. Nomad Foods Ltd. is headquartered in Feltham, the United Kingdom. “

National Presto Industries (NYSE:NPK) was downgraded by analysts at BidaskClub from a buy rating to a hold rating.

Prospect Capital Corporation (NASDAQ:PSEC) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

Qiwi Plc (NASDAQ:QIWI) was downgraded by analysts at BidaskClub from a sell rating to a strong sell rating.

Teladoc (NYSE:TDOC) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.